Lisa A. van der Kleij1, Esben T. Petersen2, Hartwig R. Siebner2, Jeroen Hendrikse1, Kristian S. Frederiksen3, Nanna A. Sobol4, Steen G. Hasselbalch3, and Ellen Garde2
1Department of Radiology, UMC Utrecht, Utrecht, Netherlands, 2Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark, 3Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, 4Musculoskeletal Rehabilitation Research Unit and Institute of Sports Medicine, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
Synopsis
The purpose of this study was to determine the effect of
moderate-to-high-intensity aerobic exercise on cerebral blood flow in patients
with Alzheimer’s disease (AD). In the ADEX trial, patients with mild to
moderate AD participated in aerobic exercise for 16 weeks. Pulsed Arterial Spin
Labeling was performed at baseline and at 16 weeks. CBF in the anterior
cingulate cortex was significantly lower at 16 weeks in the control group, but
it remained unchanged in the intervention group. Our results suggest that even brains affected by mild to moderate Alzheimer’s
disease may still benefit from regular exercise.Objective
To determine the effect of moderate-to-high-intensity
aerobic exercise on cerebral blood flow in patients with Alzheimer’s disease
(AD).
Introduction
An increasing number of studies report beneficial effect of
physical activity on brain structure and function. As well, there has been an
increasing focus in recent years on the relation between cerebrovascular health
and Alzheimer’s disease. Studies suggest a modulating effect of exercise on
both symptoms and neuropathology in patients with AD, but clarification of the underlying
mechanism is needed. In non-demented elderly physical activity has been
associated with a reduction in age-related decline in cerebral blood flow (CBF)
as well
as improved cognition
1,2. In patients with AD, a reduction in both
global and focal CBF has been found compared to healthy controls
3,4,5, and an
association has been found with cognitive functioning as measured by the Mini
Mental State Examination
6.
Methods
The ADEX study (NCT01681602) is a multicenter,
single-blind, randomized, controlled trial which aimed to investigate whether a
supervised aerobic exercise program could ameliorate symptoms of AD.
Participants
A total of 200 patients with mild to moderate AD were randomized to either an exercise group (60-minute exercise sessions 3 times a week
for 16 weeks) or to a control group (usual care). Of these a subgroup of 51 patients
underwent brain MRI at baseline and at 16 weeks7. Inclusion
criteria were amongst others an age between 50 and 90, a score of ≥20 on the
MMSE7.
Imaging
protocol
The imaging protocol on 3T (Trio,
Siemens, Erlangen, Germany) included T1-weighed magnetization-prepared rapid gradient
echo (MPRAGE) (TE 3.04ms, TR 1550ms, FoV read 256mm, FoV phase 100%, 192 slices), and pulsed arterial spin labeling (PASL) with flow-sensitive
alternating inversion recovery (FAIR) labeling scheme and a 3D
gradient-and-spin-echo (GRASE) multishot readout (TE=19ms, TR=3400ms,
FOV=320x160, matrix=64x32, slices=26, slice-thickness=4mm, TI=2000ms).
Data processing
Whole
brain CBF was calculated, and three regions were selected known to be involved
in AD and/or the neuropsychological tests administered: the frontal lobe,
anterior cingulate cortex (ACC), and superior parietal gyrus (SPG). The
T1-weighed images were segmented with Freesurfer8,9. The PASL images
were linearly registered to the MPRAGE space to select the areas for regional CBF
analysis(https://surfer.nmr.mgh.harvard.edu/fswiki/). The absolute change in
CBF (CBFfollow-up – CBFbaseline) and relative change in
CBF ((CBFfollow-up – CBFbaseline)/CBFbaseline*100%)
were calculated.
Cognitive and
physical outcome measures
The
Verbal Fluency test (VFT), Stroop test, the Symbol Digit Modalities Test (SDMT),
and the Mini Mental State Examination (MMSE) were administrated at baseline and
at 16-week follow-up. The peak oxygen uptake (VO2 peak) was recorded
at both time points.
Statistical
analysis
Statistical
analysis was carried out with R (R Foundation for Statistical Computing,
Vienna, Austria). The non-parametric statistical tests Wilcoxon rank-sum test,
Wilcoxon signed-rank test and Spearman’s correlation were used. Bonferroni
correction was used for multiple comparisons.
Results
There were no
differences in between the baseline characteristics of the intervention and
control group (see table 1). The effect of exercise was reflected in the peak oxygen
uptake: the control
group showed no change in VO
2peak, while it increased by 211 mL/min (p<0.01)
on average in the intervention group. A
significant change in CBF of on average -14 mL/100g/min was detected in the
control group in the ACC (p < .05)
whereas, no change in CBF was seen in the intervention group (figure 1).
No differences were found for the absolute and
relative CBF change between the control and intervention group for whole brain
and regional measures. Finally, no correlation was found between the change in ACC perfusion and
performance on the cognitive tasks both for all patients and within each group separately.
Discussion
CBF in the ACC was significantly lower at
16 weeks in the control group, but it remained unchanged in the intervention
group. This could indicate that moderate-to-intense aerobic exercise can
maintain regional CBF, and that through this it can as such counteract the
decline in CBF typically seen in AD. This, however,
was not reflected in changes in relevant neuropsychological tests in this study. Also, the lack of effect on whole brain CBF
could indicate that either aerobic exercise affects specific brain areas, or
that a 16-week
period is too brief to see any global effects. Our results suggest that even brains affected by mild Alzheimer’s disease may still
benefit from regular exercise.
Acknowledgements
No acknowledgement found.References
1. Ainslie PN et al. The Journal of Physiology 2008;
2. Kramer AF et al. Nature 1999
3. Asllani I et al. Journal of Cerebral Blood Flow
and Metabolism 2008;
4. Austin BP et al. Journal of Alzheimer's Disease
2011;
5. Binnewijzend MA et al. Radiology
2013;
6. Eggermont L et al. Neuroscience
and biobehavioral reviews 2006;
7. Hoffmann K et al. Neuroepidemiology 2013;
8. Fischl B et al. Neuron 2002;
9. Reuter M et al. NeuroImage 2012